Covering/Overstenting of the left subclavian artery (LSA) in thoracic endovascular repair (TEVAR) to treat various thoracic/thoracoabdominal aortic lesions - is revascularization of the left arm a must? (a retrospective cohort study of 12-years experience to describe real-world situation of daily clinical practice and review of literature)

Covering/Overstenting of the left subclavian artery (LSA) in thoracic endovascular repair (TEVAR) to treat various thoracic/thoracoabdominal aortic lesions - is revascularization of the left arm a must? (a retrospective cohort study of 12-years experience to describe real-world situation of daily clinical practice and review of literature) - TEVAR in the daily clinical setting

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023743

Enrollment

150

Registered

2020-12-21

Start date

2017-01-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I71.00 I71.03 I71.04 I71.05 I71.07 I71.1 I71.2 I71.5 I71.6 I71.8 I71.9 I77.2 I77.8 S25.0

Interventions

Group 1: Patients suffering from thoracic aortic pathologies who are either treated therapeutically with endovascular aortic reconstruction or hybrid surgery including debranching of the supra-aortic

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients underwent TEVAR / hybrid op

Exclusion criteria

Exclusion criteria: Lesion of the ascending aorta, underage patients, congenital aortic diseases, conservative treatment

Design outcomes

Primary

Measure	Time frame
Aussehen / kein Auftreten von Postop. Armischämie / Schlaganfall	—

Secondary

Measure	Time frame
Appearance / no appearance of postop. Arm ischemia / stroke in the later annual postop. control	—

Countries

Germany

Contacts

Public ContactFrank Meyer

Universitätsklinik für Allgemein-, Viszeral-, Gefäß- und Transplantationschirurgie

frank.meyer@med.ovgu.de+49-391-15682

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026